Deepti Singh

723 total citations
14 papers, 460 citations indexed

About

Deepti Singh is a scholar working on Oncology, Complementary and alternative medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Deepti Singh has authored 14 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Complementary and alternative medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Deepti Singh's work include Complementary and Alternative Medicine Studies (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and COVID-19 Clinical Research Studies (2 papers). Deepti Singh is often cited by papers focused on Complementary and Alternative Medicine Studies (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and COVID-19 Clinical Research Studies (2 papers). Deepti Singh collaborates with scholars based in India, United States and Switzerland. Deepti Singh's co-authors include Lillian L. Siu, Walter Kocha, Trudey Nicklee, Janet Dancey, Glenwood D. Goss, David W. Hedley, Gregory R. Pond, Jeremy Kortmansky, Lyly Le and Hal W. Hirte and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Deepti Singh

9 papers receiving 445 citations

Peers

Deepti Singh
Munveer S. Bhangoo United States
John E. Mignano United States
L Ausema Netherlands
Vipul T. Lakhani United States
Kvols Lk United States
Deepti Singh
Citations per year, relative to Deepti Singh Deepti Singh (= 1×) peers J E Westlin

Countries citing papers authored by Deepti Singh

Since Specialization
Citations

This map shows the geographic impact of Deepti Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepti Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepti Singh more than expected).

Fields of papers citing papers by Deepti Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepti Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepti Singh. The network helps show where Deepti Singh may publish in the future.

Co-authorship network of co-authors of Deepti Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Deepti Singh. A scholar is included among the top collaborators of Deepti Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepti Singh. Deepti Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
3.
Bhattacharjee, Hemanga K., et al.. (2022). Performance of three-dimensional and ultra-high-definition (4K) technology in laparoscopic surgery. Journal of Minimal Access Surgery. 18(2). 167–175. 7 indexed citations
4.
Nayak, Chaturbhuja, Raj Kumar Manchanda, Anil Khurana, et al.. (2020). Clinical trials of homeopathy in urological disorders: a systematic review. Journal of Complementary and Integrative Medicine. 18(1). 23–28. 4 indexed citations
5.
Singh, Deepti, Harleen Kaur, & Raj Kumar Manchanda. (2020). Integration of Homeopathy in Indian Healthcare. Homeopathy.
6.
Kaur, Harleen, Deepti Singh, & Raj Kumar Manchanda. (2019). Homeopathy in Public Health in India. Homeopathy. 108(2). 76–87. 17 indexed citations
7.
Singh, Deepti, et al.. (2015). A Review on Parkinson’s Disease: Its Pathophysiology, Treatment and Surgery. Pharmatutor. 3(2). 25–32.
8.
Singhal, Mukesh, Samir Narayan, Deepti Singh, et al.. (2014). A Phase III Trial Comparing Folfirinox Versus Gemcitabine for Metastatic Pancreatic Cancer. Annals of Oncology. 25. iv210–iv210. 16 indexed citations
9.
Goyal, Kush, Douglas B. Einstein, Min Yao, et al.. (2010). Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results. HPB Surgery. 2010. 1–8. 45 indexed citations
10.
Singh, Deepti, Linda Rath, Joseph A. Bokar, et al.. (2008). Phase I trial of erlotinib (E), modified FOLFOX6 (mFOLFOX6), and bevacizumab (B) as first-line therapy for metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 26(15_suppl). 15076–15076.
11.
Haller, Daniel G., Deepti Singh, Al B. Benson, et al.. (2006). Extended safety and efficacy data on S‐1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study. Cancer. 109(1). 33–40. 45 indexed citations
12.
Durán, Ignacio, Jeremy Kortmansky, Deepti Singh, et al.. (2006). A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. British Journal of Cancer. 95(9). 1148–1154. 260 indexed citations
13.
Mangoura, Dimitra, Yonglian Sun, Deepti Singh, et al.. (2005). Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene. 25(5). 735–745. 59 indexed citations
14.
Singh, Deepti, James H. Doroshow, L. Leong, et al.. (1992). Phase II trial of 5-fluorouracil, high-dose leucovorin calcium, and dipyridamole in advanced prostate cancer. Journal of Cancer Research and Clinical Oncology. 119(2). 117–120. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026